Question: Choose a conclusion: 1. Do not reject the null hypothesis. There is insufficient evidence to conclude that more than 94% of patients taking the drug
Choose a conclusion: 1. Do not reject the null hypothesis. There is insufficient evidence to conclude that more than 94% of patients taking the drug are healed within 8 weeks 2. Do not reject the null hypothesis. There is sufficient evidence to conclude that more than 94% of patients taking the drug are healed within eight weeks3. Reject the null hypothesis. There is sufficient evidence to conclude that more than 94% of patients taking the drug are healed within eight weeks4. Reject the no hypothesis. There is insufficient evidence to conclude that more than 94% of patients taking the drugs are healed within eight weeks

A certain drug can be used to reduce the acid produced by the body and heal damage to the esophagus due to acid reflux The manufacturer of the drug claims that more than 94% of patients taking the drug are healed within 8 weeks In clinical trials, 225 of 235 patients suffering from acid reflux disease were healed after 8 weeks Test the manufacturer's claim at the a = 0.05 level of significance. Click here to view the standard normal distribution table.(page 1). Click here to view the standard normal distribution table.(page 2). Because no ( 1 - Po) =| |10. the sample size is | 5% of the population size, and the sample the requirements for testing the hypothesis satisfied (Round to one decimal place as needed ) What are the null and alternative hypotheses? |versus H, (Type integers or decimals Do not round ) Determine the test statistic, zo zo = (Round to two decimal places as needed.) Determine the critical value(s). Select the correct choice below and fill in the answer box to complete your choice (Round to two decimal places as needed. ) O A. Za= OB. +2a/2= + Click to select your answer(s) 4:55 PM O Type here to search O C 12/12/2020
Step by Step Solution
There are 3 Steps involved in it
Get step-by-step solutions from verified subject matter experts
